Im Cannabis Corp Market Cap ($1.52 Million)
Market Cap & Net Worth: Im Cannabis Corp (IMCC)
Im Cannabis Corp market cap. Im Cannabis Corp (NASDAQ:IMCC) has a market capitalization of $1.52 Million ($1.52 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30320 globally and #6184 in its home market, demonstrating a -14.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Im Cannabis Corp's stock price $0.75 by its total outstanding shares 6223323 (6.22 Million). Also see cash flow conversion of Im Cannabis Corp for how efficiently the company converts equity into cash flow.
Im Cannabis Corp Market Cap History (2020–2026)
Im Cannabis Corp market cap history from 2020 to 2026. Data shows change from $2.91 Billion to $4.66 Million (-55.62% CAGR). Check IMCC share price today for real-time trading data and today's change.
Index Memberships
Im Cannabis Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #885 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2812 of 3165 |
Weight: Im Cannabis Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Im Cannabis Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Im Cannabis Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Im Cannabis Corp (IMCC) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.16x
Im Cannabis Corp's market cap is 0.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.91 Billion | $15.89 Million | -$28.70 Million | 183.29x | N/A |
| 2021 | $1.25 Billion | $34.05 Million | -$17.76 Million | 36.62x | N/A |
| 2022 | $36.40 Million | $54.34 Million | -$188.89 Million | 0.67x | N/A |
| 2023 | $13.33 Million | $48.80 Million | -$9.50 Million | 0.27x | N/A |
| 2024 | $14.51 Million | $54.03 Million | -$10.59 Million | 0.27x | N/A |
| 2025 | $8.65 Million | $54.73 Million | -$11.32 Million | 0.16x | N/A |
Competitor Companies of IMCC by Market Capitalization
Companies near Im Cannabis Corp in the global market cap rankings as of November 4, 2026. Also see balance sheet size of Im Cannabis Corp for a full breakdown of the balance sheet.
Key companies related to Im Cannabis Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Im Cannabis Corp (2020–2026)
Market capitalization of Im Cannabis Corp from 2020 to today. Between 2020 and today, Im Cannabis Corp's market cap moved from $2.91 Billion to $ 4.66 Million, with a yearly change of -55.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.66 Million | -46.14% |
| 2025 | $8.65 Million | -40.37% |
| 2024 | $14.51 Million | +8.83% |
| 2023 | $13.33 Million | -63.38% |
| 2022 | $36.40 Million | -97.08% |
| 2021 | $1.25 Billion | -57.18% |
| 2020 | $2.91 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Im Cannabis Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.52 Million USD |
| MoneyControl | $1.52 Million USD |
| MarketWatch | $1.52 Million USD |
| marketcap.company | $1.52 Million USD |
| Reuters | $1.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Im Cannabis Corp
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.